SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology

OBJECTIVE: Serology could help to define the real extent of SARS-CoV-2 diffusion, especially in individuals considered at higher risk of COVID-19, such as spondyloarthritis (SpA) patients undergoing immunosuppressant. Our aim was to detect, by serology, previous SARS-CoV-2 contact in SpA, compared t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortolan, Augusta, Lorenzin, Mariagrazia, Cosma, Chiara, Cozzi, Giacomo, Padoan, Andrea, Doria, Andrea, Plebani, Mario, Ramonda, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226267/
https://www.ncbi.nlm.nih.gov/pubmed/34177927
http://dx.doi.org/10.3389/fimmu.2021.682850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226267/
https://www.ncbi.nlm.nih.gov/pubmed/34177927
http://dx.doi.org/10.3389/fimmu.2021.682850

Ejemplares similares